Daihan Pharmaceutical Co.Ltd (023910) — Net Asset Quality Index
Daihan Pharmaceutical Co.Ltd (023910) has a Net Asset Quality Index of 85.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩344.02 Billion minus total liabilities of ₩50.75 Billion yields net assets of ₩293.27 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read debt load of Daihan Pharmaceutical Co.Ltd for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Daihan Pharmaceutical Co.Ltd Net Asset Quality Index Over Time (2014–2024)
This chart shows how Daihan Pharmaceutical Co.Ltd's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 85.2%, representing net assets of ₩293.27 Billion against total assets of ₩344.02 Billion KRW. For live market cap and overall valuation, see 023910 stock market capitalisation.
Annual Net Asset Quality Index for Daihan Pharmaceutical Co.Ltd (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Daihan Pharmaceutical Co.Ltd from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check Daihan Pharmaceutical Co.Ltd (023910) strategic asset index to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 85.1% | ₩275.99 Billion | ₩324.41 Billion | ₩48.42 Billion | ▲ +0.8 pp |
| 2023 | 84.3% | ₩247.97 Billion | ₩294.25 Billion | ₩46.28 Billion | ▲ +2.9 pp |
| 2022 | 81.4% | ₩225.40 Billion | ₩276.98 Billion | ₩51.58 Billion | ▲ +7.0 pp |
| 2021 | 74.4% | ₩202.81 Billion | ₩272.54 Billion | ₩69.73 Billion | ▲ +2.5 pp |
| 2020 | 71.9% | ₩181.92 Billion | ₩253.09 Billion | ₩71.17 Billion | ▲ +4.3 pp |
| 2019 | 67.6% | ₩166.78 Billion | ₩246.85 Billion | ₩80.08 Billion | ▲ +7.8 pp |
| 2018 | 59.8% | ₩140.36 Billion | ₩234.75 Billion | ₩94.39 Billion | ▼ -3.0 pp |
| 2017 | 62.8% | ₩115.88 Billion | ₩184.40 Billion | ₩68.52 Billion | ▲ +4.9 pp |
| 2016 | 58.0% | ₩92.94 Billion | ₩160.31 Billion | ₩67.36 Billion | ▲ +2.6 pp |
| 2015 | 55.3% | ₩76.84 Billion | ₩138.83 Billion | ₩61.99 Billion | ▲ +6.6 pp |
| 2014 | 48.7% | ₩64.10 Billion | ₩131.61 Billion | ₩67.52 Billion | — |